产品特点
1
_ _
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Felimazole 2.5 mg Coated Tablets for Cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Thiamazole
2.5 mg
EXCIPIENTS:
Titanium Dioxide (E171)
1.12 mg
Erythrosine (E127)
0.01 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Coated tablet.
Pink sugar-coated biconvex tablets, 5.5 mm diameter.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy.
For the long-term treatment of feline hyperthyroidism.
4.3
CONTRAINDICATIONS
Do not use in cats suffering from systemic disease such as primary liver disease or diabetes
mellitus.
Do not use in cats showing signs of autoimmune disease.
Do not use in animals with disorders of white blood cells, such as neutropenia and
lymphopenia.
Do not use in animals with platelet disorders and coagulopathies (particularly
thrombocytopenia).
Do not use in cats with hypersensitivity to thiamazole or the excipient, polyethylene glycol.
Do not use in pregnant or lactating females.
Please refer to section 4.7.
4.4
SPECIAL WARNINGS
As thiamazole can cause haemoconcentration, cats should always have access to drinking
water.
3
4.5
SPECIAL PRE CAUTIONS FOR USE
S
阅读完整的文件